Literature DB >> 18583895

A case of a patient with both chorea and restless legs syndrome.

Yoon-Kyung Shin1, Seung-Chul Hong, Yon Kwon Ihn, Jong-Hyun Jeong, Jin-Hee Han, Sung-Pil Lee.   

Abstract

The patient was a 44-yr-old man with end-stage renal disease who had developed chorea as a result of hypoglycemic injury to the basal ganglia and thalamus and who was subsequently diagnosed with depression and restless legs syndrome (RLS). For proper management, the presence of a complex medical condition including two contrasting diseases, chorea and RLS, had to be considered. Tramadol improved the pain and dysesthetic restlessness in his feet and legs, and this was gradually followed by improvements in his depressed mood, insomnia, lethargy, and feelings of hopelessness. This case suggests that the dopaminergic system participates intricately with the opioid, serotoninergic, and noradrenergic systems in the pathophysiology of RLS and pain and indirectly of depression and insomnia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583895      PMCID: PMC2526510          DOI: 10.3346/jkms.2008.23.3.533

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  13 in total

Review 1.  Restless legs syndrome: a review of clinical and pathophysiologic features.

Authors:  R P Allen; C J Earley
Journal:  J Clin Neurophysiol       Date:  2001-03       Impact factor: 2.177

2.  Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

Authors:  N Turjanski; A J Lees; D J Brooks
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

3.  CSF iron, ferritin and transferrin levels in restless legs syndrome.

Authors:  Soichi Mizuno; Takumi Mihara; Tsuyoshi Miyaoka; Takuzi Inagaki; Jun Horiguchi
Journal:  J Sleep Res       Date:  2005-03       Impact factor: 3.981

Review 4.  Seminar on choreas.

Authors:  Francisco Cardoso; Klaus Seppi; Katherina J Mair; Gregor K Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

5.  SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep.

Authors:  Martin Michaud; Jean-Paul Soucy; Allal Chabli; Gilles Lavigne; Jacques Montplaisir
Journal:  J Neurol       Date:  2002-02       Impact factor: 4.849

6.  Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.

Authors:  C Brodeur; J Montplaisir; R Godbout; R Marinier
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

Review 7.  Primate models of movement disorders of basal ganglia origin.

Authors:  M R DeLong
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

8.  Subclinical sensory neuropathy in late-onset restless legs syndrome.

Authors:  M Polydefkis; R P Allen; P Hauer; C J Earley; J W Griffin; J C McArthur
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

9.  Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.

Authors:  W Löscher; D Hönack; C P Taylor
Journal:  Neurosci Lett       Date:  1991-07-22       Impact factor: 3.046

10.  Gabapentin augments whole blood serotonin in healthy young men.

Authors:  M L Rao; P Clarenbach; M Vahlensieck; S Krätzschmar
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.